查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1298659

肝病治疗市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Liver Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球肝病治疗市场规模达到223亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到330亿美元，在2023-2028年期间呈现6.43%的增长率（CAGR）。

肝脏是人体的一个重要器官，发挥着重要的功能，如储存维生素和营养物质，清除血液中的有害物质，并保持体内化学物质的充分平衡。癌症、肝炎、自身免疫性疾病和遗传性疾病是一些常见的肝病。这些疾病通常由感染、遗传、肥胖、糖尿病和免疫系统异常引起。一些广泛使用的肝病治疗技术包括疫苗、化疗、抗病毒药物、免疫球蛋白、皮质类固醇和免疫抑制剂。肝病治疗有助于胆固醇和荷尔蒙的排泄，增加胆汁分泌和酶的激活。

肝病治疗的市场趋势：

全球范围内的老年人口不断增加，容易出现各种慢性疾病，包括肝病，这是推动市场增长的主要因素之一。饮食模式的改变和久坐的生活方式正在推动市场的增长。此外，由于高胆固醇、肥胖、高血压和糖尿病导致的脂肪肝发病率的增加，也有利于市场的增长。此外，各种技术进步，如生物人工肝的开发，正在为市场增长提供动力。它利用再生的肝脏细胞来替代肝脏功能，广泛用于急性肝衰竭患者。与此相应，抗病毒药物的迅速采用，因为它们安全有效，协助抑制乙型肝炎病毒，并有助于降低患肝硬化和肝细胞癌的风险，正在对市场增长产生积极的影响。除此之外，研究和开发（R&D）活动的增加，医疗保健行业的显著增长，以及政府为促进公众健康而采取的各种倡议，都为市场创造了积极的前景。

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球肝病治疗市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按治疗类型分類的市场

  • 抗病毒药物
    • 市场趋势
    • 市场预测
  • 免疫抑制剂
    • 市场趋势
    • 市场预测
  • 疫苗
    • 市场趋势
    • 市场预测
  • 免疫球蛋白
    • 市场趋势
    • 市场预测
  • 皮质类固醇
    • 市场趋势
    • 市场预测
  • 靶向治疗
    • 市场趋势
    • 市场预测
  • 化疗
    • 市场趋势
    • 市场预测

第7章 ：按疾病类型分類的市场

  • 肝炎
    • 市场趋势
    • 市场预测
  • 自身免疫性疾病
    • 市场趋势
    • 市场预测
  • 非酒精性脂肪肝(NAFLD)
    • 市场趋势
    • 市场预测
  • 癌症
    • 市场趋势
    • 市场预测
  • 遗传性疾病
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第8章：按终端用户分類的市场

  • 医院
    • 市场趋势
    • 市场预测
  • 非住院手术中心
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十章：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十一章 ：价值链分析

第十二章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章 ：价格分析

第十四章：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • Abbott Laboratories
    • AbbVie Inc.
    • Astellas Pharma Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Emergent BioSolutions Inc.
    • F. Hoffmann-La Roche AG
    • Gilead Sciences Inc.
    • GlaxoSmithKline plc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Takeda Pharmaceutical Company Limited
    • Viatris Inc.
Product Code: SR112023A5023

The global liver disease treatment market size reached US$ 22.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.43% during 2023-2028.

The liver is a vital organ of the human body that performs significant functions, such as storing vitamins and nutrients, removing harmful substances from the blood, and maintaining an adequate balance of chemicals in the body. Cancer, hepatitis, autoimmune diseases, and genetic disorders are some common liver diseases. These diseases are commonly caused by infections, genetics, obesity, diabetes, and immune system abnormalities. Some of the widely used therapeutic techniques for liver diseases include vaccines, chemotherapy, antiviral drugs, immunoglobulins, corticosteroids, and immunosuppressants. Liver disease treatment aids in the excretion of cholesterol and hormones, increases bile production and enzyme activation.

Liver Disease Treatment Market Trends:

The rising geriatric population, which is suspetible to various chronic ailments, including liver disease, across the globe is one of the prime factors driving the growth of the market. The changing dietary patterns and sedentary lifestyles are boosting the market growth. Additionally, the increasing prevalence of fatty liver disease due to high cholesterol, obesity, hypertension (high blood pressure), and diabetes is favoring the market growth. Moreover, various technological advancements, such as the development of the bioartificial liver, are providing an impetus to the market growth. It utilizes regenerated liver cells to replace liver functions and is widely used for acute liver failure patients. In line with this, the rapid adoption of antiviral drugs as they are safe and effective, assist in suppressing the hepatitis B virus, and help in reducing the risk of developing cirrhosis and hepatocellular carcinoma, is positively impacting the market growth. Apart from this, increasing research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives to promote public health are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global liver disease treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on treatment type, disease type and end user.

Breakup by Treatment Type:

Antiviral Drugs

Immunosuppressants

Vaccines

Immunoglobulins

Corticosteroids

Targeted Therapy

Chemotherapy

Breakup by Disease Type:

Hepatitis

Autoimmune Diseases

Non-alcoholic Fatty Liver Disease (NAFLD)

Cancer

Genetic Disorders

Others

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.

Key Questions Answered in This Report

1. What was the size of the global liver disease treatment market in 2022?

2. What is the expected growth rate of the global liver disease treatment market during 2023-2028?

3. What are the key factors driving the global liver disease treatment market?

4. What has been the impact of COVID-19 on the global liver disease treatment market?

5. What is the breakup of the global liver disease treatment market based on the treatment type?

6. What is the breakup of the global liver disease treatment market based on the disease type?

7. What is the breakup of the global liver disease treatment market based on the end user?

8. What are the key regions in the global liver disease treatment market?

9. Who are the key players/companies in the global liver disease treatment market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Liver Disease Treatment Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Treatment Type

  • 6.1  Antiviral Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Vaccines
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Immunoglobulins
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Corticosteroids
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  Targeted Therapy
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Chemotherapy
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7   Market Breakup by Disease Type

  • 7.1  Hepatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Autoimmune Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Non-alcoholic Fatty Liver Disease (NAFLD)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  Genetic Disorders
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6  Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2  AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  Astellas Pharma Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5  Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6  Emergent BioSolutions Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7  F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8  Gilead Sciences Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9  GlaxoSmithKline plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10  Merck & Co. Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  Novartis AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12  Pfizer Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13  Sanofi S.A.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
    • 14.3.14  Takeda Pharmaceutical Company Limited
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials
      • 14.3.14.4 SWOT Analysis
    • 14.3.15  Viatris Inc.
      • 14.3.15.1 Company Overview
      • 14.3.15.2 Product Portfolio
      • 14.3.15.3 Financials

List of Figures

  • Figure 1: Global: Liver Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Liver Disease Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Liver Disease Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Liver Disease Treatment Market: Breakup by Treatment Type (in %), 2022
  • Figure 5: Global: Liver Disease Treatment Market: Breakup by Disease Type (in %), 2022
  • Figure 6: Global: Liver Disease Treatment Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Liver Disease Treatment Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Liver Disease Treatment (Antiviral Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Liver Disease Treatment (Antiviral Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Liver Disease Treatment (Immunosuppressants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Liver Disease Treatment (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Liver Disease Treatment (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Liver Disease Treatment (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Liver Disease Treatment (Immunoglobulins) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Liver Disease Treatment (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Liver Disease Treatment (Corticosteroids) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Liver Disease Treatment (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Liver Disease Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Liver Disease Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Liver Disease Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Liver Disease Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Liver Disease Treatment (Hepatitis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Liver Disease Treatment (Hepatitis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Liver Disease Treatment (Autoimmune Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Liver Disease Treatment (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Liver Disease Treatment (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Liver Disease Treatment (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Liver Disease Treatment (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Liver Disease Treatment (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Liver Disease Treatment (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Liver Disease Treatment (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Liver Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Liver Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Liver Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Liver Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia-Pacific: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia-Pacific: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Liver Disease Treatment Market: Breakup by Country (in %), 2022
  • Figure 88: Middle East and Africa: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Liver Disease Treatment Industry: SWOT Analysis
  • Figure 90: Global: Liver Disease Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Liver Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Liver Disease Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Liver Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 3: Global: Liver Disease Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
  • Table 4: Global: Liver Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Liver Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Liver Disease Treatment Market: Competitive Structure
  • Table 7: Global: Liver Disease Treatment Market: Key Players